Kenvue Inc.
Kenvue Inc. Shareholders Elect Directors and Approve Compensation at 2025 Annual Meeting
Summary
Kenvue Inc. held its 2025 Annual Meeting of Shareholders on May 22, 2025. Shareholders elected all 13 director nominees to the Company's Board of Directors. They also approved, on a non-binding advisory basis, the compensation of the Company's named executive officers and ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2025.
Profitelligence Alerts
Get alerts for KVUE
Be first to know when Kenvue Inc. files with the SEC.
Filing Categories
Advertisement
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Official SEC Documents
Advertisement